Abbott (ABT) Reports In-Line Q4 EPS, Guides FY19 EPS In-Line

Abbott (NYSE: ABT) reported Q4 EPS of $0.81, in-line with the analyst estimate of $0.81. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.82 billion.

GUIDANCE:

Abbott sees FY2019 EPS of $3.15-$3.25, versus the consensus of $3.20.

• Abbott issues full-year 2019 guidance for organic sales growth of 6.5 to 7.5 percent

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Palantir surges 4% on Nvidia sovereign AI pact as software beats semis